5 quarters tracked · Beat rate 80% · Updated quarterly
| Period | Report Date | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.14 | $3.09 | +44.1% | Beat |
| Q1 2026 | 2026-03-31 | $1.40 | $1.81 | +29.4% | Beat |
| Q4 2025 | 2025-12-31 | $1.97 | $1.80 | -8.5% | Miss |
| Q3 2025 | 2025-09-30 | $1.69 | $2.26 | +33.7% | Beat |
| Q2 2025 | 2025-06-30 | $1.50 | $1.57 | +4.7% | Beat |
Earnings Beat Rate
Incyte has beaten analyst EPS estimates in 4 of 5 tracked quarters (80% beat rate). Data sourced from SEC filings and analyst consensus. View full AI analysis →